Australia Spinal Surgery Devices Market Trends

The growth of the spinal fusion devices segment is majorly driven by the increase in the geriatric population and the rise in the incidence of spinal disorders. For instance, according to the Australian Bureau of Statistics (ABS), the number of Australians aged 85 and over is expected to double by 2042, reaching almost 1 million people, according to the most recent population forecasts published in 2018. The population of Australia is expected to continue to age as a result of low fertility paired with rising life expectancy, with the number of people aged 65 and above expected to nearly double from 3.8 million in 2017 to between 6.4 million and 6.7 million in 2042. As this population is more prone to back pain and spinal conditions, the demand for procedures such as artificial disc replacement and devices like spinal fusion devices is likely to increase over the coming years, thereby boosting the segment growth. In addition, the expansion in indications for which spinal fusion surgery is performed, including in the cervical fusion market, boosts the market growth. These devices, including vertebral implants, spinal cage, and spine implants, are intended to treat disc degenerative diseases, spine injuries, and other disorders pertaining to the cervical, thoracic, and lumbar areas of the spine. Thus, the growing prevalence of these disorders is attributable to the large share of the segment.